Biocorrx Inc. (OTCMKTS:BICX) Stock Short Interest Declines 44.3%

Biocorrx Inc. (OTCMKTS:BICX) was the target of a large decline in short interest in the month of September. As of September 15th, there was short interest totaling 10,083 shares, a decline of 44.3% from the August 31st total of 18,093 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average daily volume of 2,494 shares, the days-to-cover ratio is presently 4.0 days.

Biocorrx Stock Up 5.5%

Shares of OTCMKTS:BICX traded up $0.01 on Thursday, hitting $0.21. The company had a trading volume of 500 shares, compared to its average volume of 6,514. The firm’s 50-day simple moving average is $0.25 and its two-hundred day simple moving average is $0.32. Biocorrx has a 1 year low of $0.15 and a 1 year high of $1.28. The firm has a market capitalization of $6.41 million, a price-to-earnings ratio of -1.77 and a beta of 0.19.

Biocorrx (OTCMKTS:BICX) last announced its quarterly earnings results on Friday, August 14th. The company reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.05) by $0.02. The company had revenue of $0.09 million for the quarter, compared to analysts’ expectations of $0.24 million.

Biocorrx Company Profile

BioCorRx Inc develops addiction treatment programs and related products designed to support individuals seeking recovery from alcohol and substance use disorders. The company’s offerings include the BioCorRx Recovery Program, which combines an initial detoxification protocol with counseling, behavioral support and ongoing recovery services. BioCorRx describes the program as non-addictive and designed to be delivered through qualified treatment providers.

The company also develops and markets nutritional supplements intended to support recovery and help address cravings and related wellness needs.